1) Prepare the following consolidation and equity accounting entries for Purple Co. and its subseries and Associate for the year ended 31 December 20X5.


1) Prepare the following consolidation and equity accounting entries for Purple Co. and its subseries and Associate for the year ended 31 December 20X5.                                                                

CJE1: Elimination of investment in Yellow Co.;

Dr. share capital (Yellow Co.)

$ 3,120,000

Dr. Retained Earnings (Yellow Co.)

$ 3,510,000

Dr. Goodwill

$ 1,560,000

Cr. Investment In (Yellow Co.)

$ 8,580,000

Cr. Non-Controlling Interest (NCI)

$ 1,610,000